[ESPR] QoQ Quarter Result on 31-Mar-2002 [#Q1]

Stock
[ESPR] Esperion Therapeutics, Inc.
Announcement Date
30-Mar-2002
Financial Year
2002
Quarter
31-Mar-2002 [#Q1]
Profit Trend
QoQ- -15.12%
YoY- -22.10%
Quarter Report
ESPR's Result
ESPR's Financial Summary
View:
Show?
Quarter Result
31/12/02 30/09/02 30/06/02 31/03/02 31/12/01 30/09/01 30/06/01 CAGR
Revenue 0 0 0 0 0 0 1 -
PBT -6,619 -6,980 -7,824 -7,303 -6,344 -6,281 -6,325 3.06%
Tax 692 177 888 314 -112 736 -454 -
NP -6,619 -6,980 -7,824 -7,303 -6,344 -6,281 -6,325 3.06%
Tax Rate - - - - - - - -
Total Cost 6,619 6,980 7,824 7,303 6,344 6,281 6,326 3.05%
Ratio Analysis
31/12/02 30/09/02 30/06/02 31/03/02 31/12/01 30/09/01 30/06/01 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 -632,500.00 -
Per Share
31/12/02 30/09/02 30/06/02 31/03/02 31/12/01 30/09/01 30/06/01 CAGR
EPS -1.58 -1.67 -1.87 -1.75 -1.57 -1.56 -1.70 -4.75%
EPS Diluted -1.58 -1.67 -1.87 -1.75 -1.57 -1.56 -1.70 -4.75%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.